Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00261729 · ClinicalTrials.gov registry record · NA
Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
NCT00261729 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 210 participants.
The verdict
NCT00261729, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
Study Summary
Evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from OIF and OEF. To evaluate the effects of the SSRI paroxetine on behavioral symptoms and overall function in this population.
Interventions
- DRUG placebo
- DRUG Prazosin
- DRUG Paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00261729
The ClinicalTrials.gov registry entry for NCT00261729 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00261729 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00261729 about?
NCT00261729 is a clinical study titled "Prazosin vs. Paroxetine in Combat Stress Symptoms in OIF/OEF Returnees". Evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from OIF and OEF. To evaluate the effects of the SSRI paroxetine on behavioral symptoms and overall functi...
What is the current status of trial NCT00261729?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2004-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00261729?
The interventions under investigation include: placebo (DRUG), Prazosin (DRUG), Paroxetine (DRUG).
Who is sponsoring clinical trial NCT00261729?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.